We firmly believe in the fact that the inhalation preparation is and will be the mainstream product in the market.
Our products will be approved in China and EU from year 2021 and on, and with a global sell, we will be a leading company in inhalation products and eyedrops soon.
Events
-
2021-02-02Aureole's Salbutamol Sulfate Inhalation Solution Recieved CDE Reference Number
The Salbutamol Sulfate Inhalation Solution (2.5ml:2.5mg ) and the Salbutamol Sulfate Inhalation Solution (2.5ml:5mg ), which researched and developed independently by Aureole and is the first product to register, receives the reference number issued by CDE on NovMore